COMMUNIQUÉS West-GlobeNewswire
-
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
22/07/2026 -
Jushi Holdings Inc. to Report Second Quarter 2026 Financial Results on July 28, 2026
21/07/2026 -
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
21/07/2026 -
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
21/07/2026 -
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
21/07/2026 -
Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC
22/07/2026 -
Blink Anesthesia Appoints Three New Board Members
21/07/2026 -
NMDP Celebrates Bipartisan House Passage of Life-Saving Stem Cell Therapeutic and Research Reauthorization Act
21/07/2026 -
Acquisition of Own Shares
21/07/2026 -
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
21/07/2026 -
Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
21/07/2026 -
Dentsply Sirona to Host Second Quarter Conference Call on August 6th
21/07/2026 -
A Child's Light Announces Receipt of $6,500 Grant to Expedite Youth Mental Health Care
21/07/2026 -
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
21/07/2026 -
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis
21/07/2026 -
Flyte Partners with Blade to Expand Vision Jet Distribution
21/07/2026 -
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
21/07/2026 -
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
21/07/2026 -
Summer Hair Restoration Promo Now Available at Cross Medical Group
21/07/2026
Pages